Zarminali Pediatrics has raised $110 million in a Series A funding round to scale its outpatient pediatric care model nationwide, with continued backing from General Catalyst.
The round was led by Healthier Capital and included participation from General Catalyst and new investor K2 HealthVentures, according to a Jan. 21 news release. The latest funding brings the company’s total capital raised to $150 million since its founding in 2024.
Zarminali Pediatrics currently operates 28 clinics across eight states and plans to open 15 additional clinics in 2026, including locations in Chicago, Milwaukee and Dallas.
The capital will support the acceleration of Zarminali’s proprietary technology platform, entry into new markets and the opening of newly built pediatric clinics. The company also plans to expand beyond primary care to include urgent care and specialty services.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
